A citation-based method for searching scientific literature

Melissa C Southey, Mark A Jenkins, Leeanne Mead, Jonathan Whitty, Melanie Trivett, Andrea A Tesoriero, Letitia D Smith, Kim Jennings, Garry Grubb, Simon G Royce, Michael D Walsh, Melissa A Barker, Joanne P Young, Jeremy R Jass, D James B St John, Finlay A Macrae, Graham G Giles, John L Hopper. J Clin Oncol 2005
Times Cited: 172

List of co-cited articles
921 articles co-cited >1

Times Cited
  Times     Co-cited

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Asad Umar, C Richard Boland, Jonathan P Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralane M Lindor, Lawrence J Burgart, Richard Hamelin,[...]. J Natl Cancer Inst 2004

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Hidewaki Nakagawa, Kaisa Sotamaa, Thomas W Prior, Judith Westman,[...]. N Engl J Med 2005

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.
Leigha Senter, Mark Clendenning, Kaisa Sotamaa, Heather Hampel, Jane Green, John D Potter, Annika Lindblom, Kristina Lagerstedt, Stephen N Thibodeau, Noralane M Lindor,[...]. Gastroenterology 2008

Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Mark Clendenning, Kaisa Sotamaa, Thomas Prior, Judith A Westman,[...]. J Clin Oncol 2008

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
C R Boland, S N Thibodeau, S R Hamilton, D Sidransky, J R Eshleman, R W Burt, S J Meltzer, M A Rodriguez-Bigas, R Fodde, G N Ranzani,[...]. Cancer Res 1998

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H J Järvinen, M Aarnio, H Mustonen, K Aktan-Collan, L A Aaltonen, P Peltomäki, A De La Chapelle, J P Mecklin. Gastroenterology 2000

Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.
Polly A Newcomb, John Baron, Michelle Cotterchio, Steve Gallinger, John Grove, Robert Haile, David Hall, John L Hopper, Jeremy Jass, Loïc Le Marchand,[...]. Cancer Epidemiol Biomarkers Prev 2007

Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
L A Aaltonen, R Salovaara, P Kristo, F Canzian, A Hemminki, P Peltomäki, R B Chadwick, H Kääriäinen, M Eskelinen, H Järvinen,[...]. N Engl J Med 1998

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).
H F Vasen, J P Mecklin, P M Khan, H T Lynch. Dis Colon Rectum 1991

Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.
Rebecca A Barnetson, Albert Tenesa, Susan M Farrington, Iain D Nicholl, Roseanne Cetnarskyj, Mary E Porteous, Harry Campbell, Malcolm G Dunlop. N Engl J Med 2006

Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer.
Andrea E de Jong, Marjo van Puijenbroek, Yvonne Hendriks, Carli Tops, Juul Wijnen, Margreet G E M Ausems, Hanne Meijers-Heijboer, Anja Wagner, Theo A M van Os, Annette H J T Bröcker-Vriends,[...]. Clin Cancer Res 2004

Identification of Lynch syndrome among patients with colorectal cancer.
Leticia Moreira, Francesc Balaguer, Noralane Lindor, Albert de la Chapelle, Heather Hampel, Lauri A Aaltonen, John L Hopper, Loic Le Marchand, Steven Gallinger, Polly A Newcomb,[...]. JAMA 2012

Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.
Susan Parry, Aung Ko Win, Bryan Parry, Finlay A Macrae, Lyle C Gurrin, James M Church, John A Baron, Graham G Giles, Barbara A Leggett, Ingrid Winship,[...]. Gut 2011

Hereditary colorectal cancer.
Henry T Lynch, Albert de la Chapelle. N Engl J Med 2003

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.
Glenn E Palomaki, Monica R McClain, Stephanie Melillo, Heather L Hampel, Stephen N Thibodeau. Genet Med 2009

Risks of Lynch syndrome cancers for MSH6 mutation carriers.
Laura Baglietto, Noralane M Lindor, James G Dowty, Darren M White, Anja Wagner, Encarna B Gomez Garcia, Annette H J T Vriends, Nicola R Cartwright, Rebecca A Barnetson, Susan M Farrington,[...]. J Natl Cancer Inst 2010

Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.
Noralane M Lindor, Lawrence J Burgart, Olga Leontovich, Richard M Goldberg, Julie M Cunningham, Daniel J Sargent, Catherine Walsh-Vockley, Gloria M Petersen, Michael D Walsh, Barbara A Leggett,[...]. J Clin Oncol 2002

Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
Virgínia Piñol, Antoni Castells, Montserrat Andreu, Sergi Castellví-Bel, Cristina Alenda, Xavier Llor, Rosa M Xicola, Francisco Rodríguez-Moranta, Artemio Payá, Rodrigo Jover,[...]. JAMA 2005

Population-based molecular detection of hereditary nonpolyposis colorectal cancer.
R Salovaara, A Loukola, P Kristo, H Kääriäinen, H Ahtola, M Eskelinen, N Härkönen, R Julkunen, E Kangas, S Ojala,[...]. J Clin Oncol 2000

Prediction of germline mutations and cancer risk in the Lynch syndrome.
Sining Chen, Wenyi Wang, Shing Lee, Khedoudja Nafa, Johanna Lee, Kathy Romans, Patrice Watson, Stephen B Gruber, David Euhus, Kenneth W Kinzler,[...]. JAMA 2006

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.
E Domingo, P Laiho, M Ollikainen, M Pinto, L Wang, A J French, J Westra, T Frebourg, E Espín, M Armengol,[...]. J Med Genet 2004

The search for unaffected individuals with Lynch syndrome: do the ends justify the means?
Heather Hampel, Albert de la Chapelle. Cancer Prev Res (Phila) 2011

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Valérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, Sophie Grandjouan, Laetitia Huiart, Michel Longy, Rosine Guimbaud, Bruno Buecher, Yves-Jean Bignon, Olivier Caron,[...]. JAMA 2011

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.
Marjolijn J L Ligtenberg, Roland P Kuiper, Tsun Leung Chan, Monique Goossens, Konnie M Hebeda, Marsha Voorendt, Tracy Y H Lee, Danielle Bodmer, Eveline Hoenselaar, Sandra J B Hendriks-Cornelissen,[...]. Nat Genet 2009

Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.
Aung Ko Win, Joanne P Young, Noralane M Lindor, Katherine M Tucker, Dennis J Ahnen, Graeme P Young, Daniel D Buchanan, Mark Clendenning, Graham G Giles, Ingrid Winship,[...]. J Clin Oncol 2012

A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines.
M A Rodriguez-Bigas, C R Boland, S R Hamilton, D E Henson, J R Jass, P M Khan, H Lynch, M Perucho, T Smyrk, L Sobin,[...]. J Natl Cancer Inst 1997

Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Kathleen M Schmeler, Henry T Lynch, Lee-may Chen, Mark F Munsell, Pamela T Soliman, Mary Beth Clark, Molly S Daniels, Kristin G White, Stephanie G Boyd-Rogers, Peggy G Conrad,[...]. N Engl J Med 2006

Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.
Uri Ladabaum, Grace Wang, Jonathan Terdiman, Amie Blanco, Miriam Kuppermann, C Richard Boland, James Ford, Elena Elkin, Kathryn A Phillips. Ann Intern Med 2011

Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study.
Mark A Jenkins, Laura Baglietto, James G Dowty, Christine M Van Vliet, Letitia Smith, Leeanne J Mead, Finlay A Macrae, D James B St John, Jeremy R Jass, Graham G Giles,[...]. Clin Gastroenterol Hepatol 2006

Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms.
Jinru Shia, David S Klimstra, Khedoudja Nafa, Kenneth Offit, Jose G Guillem, Arnold J Markowitz, William L Gerald, Nathan A Ellis. Am J Surg Pathol 2005

Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.
R C Niessen, M J W Berends, Y Wu, R H Sijmons, H Hollema, M J L Ligtenberg, H E K de Walle, E G E de Vries, A Karrenbeld, C H C M Buys,[...]. Gut 2006

Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
Geoffrey Hall, Adele Clarkson, Amanda Shi, Eileen Langford, Helen Leung, Robert P Eckstein, Anthony J Gill. Pathology 2010

Microsatellite instability in cancer of the proximal colon.
S N Thibodeau, G Bren, D Schaid. Science 1993

Population carrier frequency of hMSH2 and hMLH1 mutations.
M G Dunlop, S M Farrington, I Nicholl, L Aaltonen, G Petersen, M Porteous, A Carothers. Br J Cancer 2000

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
Christine M Ribic, Daniel J Sargent, Malcolm J Moore, Stephen N Thibodeau, Amy J French, Richard M Goldberg, Stanley R Hamilton, Pierre Laurent-Puig, Robert Gryfe, Lois E Shepherd,[...]. N Engl J Med 2003

Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study.
Mark A Jenkins, Shinichi Hayashi, Anne-Marie O'Shea, Lawrence J Burgart, Tom C Smyrk, David Shimizu, Paul M Waring, Andrew R Ruszkiewicz, Aaron F Pollett, Mark Redston,[...]. Gastroenterology 2007

Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls.
S M Farrington, J Lin-Goerke, J Ling, Y Wang, J D Burczak, D J Robbins, M G Dunlop. Am J Hum Genet 1998

Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases.
Kandelaria Rumilla, Karen V Schowalter, Noralane M Lindor, Brittany C Thomas, Kara A Mensink, Steven Gallinger, Spring Holter, Polly A Newcomb, John D Potter, Mark A Jenkins,[...]. J Mol Diagn 2011

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications.
H T Lynch, P M Lynch, S J Lanspa, C L Snyder, J F Lynch, C R Boland. Clin Genet 2009

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.
Hans F A Vasen, Ignacio Blanco, Katja Aktan-Collan, Jessica P Gopie, Angel Alonso, Stefan Aretz, Inge Bernstein, Lucio Bertario, John Burn, Gabriel Capella,[...]. Gut 2013

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015

Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.
Yvonne M C Hendriks, Anja Wagner, Hans Morreau, Fred Menko, Astrid Stormorken, Franz Quehenberger, Lodewijk Sandkuijl, Pal Møller, Maurizio Genuardi, Hans Van Houwelingen,[...]. Gastroenterology 2004

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.